Pursuant to section 52(1) of the New Zealand Public Health and Disability Act 2000 ("the NZPHD Act") and notice given under section 28(2) of the Crown Entities Act 2004 ("the CE Act"), I have appointed
Stuart James McLauchlan
as a member, under section 28(1)(a) of the CE Act, of the board of the Pharmaceutical Management Agency.
Pursuant to clause 1(1) of Schedule 5 to the CE Act, I have also appointed
Stuart James McLauchlan
as deputy chairperson of the board of the Pharmaceutical Management Agency.
These appointments will both take effect on 1 August 2009 and will end on 31 July 2012.
Dated at Wellington this 31st day of July 2009.
HON TONY RYALL, Minister of Health.